ADAMIS PHARMACEUTICL Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
Adamis Enters Distribution Agreement With Novartis Unit Sandoz
Article By: The Fly Monday, July 2, 2018 8:37 AM EDT
Adamis Pharmaceuticals announced last night that it has entered into an exclusive distribution and commercialization agreement with Sandoz, a division of Novartis.
In this article: NVS, ADMP Also: MYL
Read
Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Friday, April 21, 2017 5:33 PM EDT
Adamis Pharmaceuticals Corporation announced today the pricing of its previously announced underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $3.50 per share.
In this article: ADMP
Read
E Today’s Top Trending Stocks - Tuesday, Mar. 7
Article By: Small Cap Reporter Tuesday, March 7, 2017 6:02 PM EDT
Today's most active and buzz-worthy small cap stocks.
In this article: UBQU, OGRMF, AUPH, ADMP
Read
T2108 Update – Still Waiting For Volatility’s Moment
Article By: Dr. Duru Tuesday, September 6, 2016 4:04 AM EDT
Along with the plunge in volatility, the S&P 500 gapped back into the middle of the current trading range. The move left behind two straight days where sellers seemed to be ready to break the index down.
In this article: CORN, ADMP, USCR, DATA, IBB, IPXL, MYL, SPY, TWTR, VIX
Read
Why Is Adamis Pharmaceuticals Corporation So Hot Right Now?
Article By: Insider Monkey Monday, May 9, 2016 9:45 PM EDT
Adamis Pharmaceuticals Corporation shares lost more than 30% of their value at one point in August. However, it was our highest conviction idea, so we kept our buy recommendation over the last 12 months.
In this article: ADMP
Read
ADMP Announces Positive Results For Its Dry Powder Inhaler Product; BOTA Commences Dosing In Vapendavir Phase 2b Trial
Article By: BioMedReports Wednesday, March 4, 2015 5:15 AM EDT
ADMP announced the results of its pharmacokinetic (PK) study for its dry powder inhaler product, APC-5000. BOTA announced it has commenced dosing of patients in its Phase 2b SPIRITUS trial of vapendavir.
In this article: ADMP, BOTA
Read
EnteroMedics Spikes Up Following FDA Approval Of Neuroblocking Obesity Device
Article By: BioMedReports Wednesday, January 14, 2015 10:26 PM EDT
Also, pSivida Corp. announces sales of Iluvien for diabetic macular edema has begun in Portugal.
In this article: ETRM, PSDV, ADMP, ATHN, ASPX, BCRX, FBRC, FWDG, RHHBY, IART, MANT, MASI, MCIG, BABY, OSUR, PZOO, SBRA, TNXP
Read
1 to 7 of 7 Posts